Evidence map›Paper›PMID 36988250›Full record

ArticleImmunity, inflammation and disease2023

NCR negative group 3 innate lymphoid cell (NCR

Shuyuan Chu, Libing Ma, Xia Yang, Bo Xiao, Yaxi Liang, Shaojie Zheng, Linqiao Li

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunity, inflammation and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. NCR negative group 3 innate lymphoid cell (NCRImmunity, inflammation and disease · 2023
    Article
  5. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shuyuan ChuLaboratory of Respiratory Disease, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.ORCID 0000-0002-1543-0877
Libing MaDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Xia YangDepartment of General Practice, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Bo XiaoLaboratory of Respiratory Disease, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Yaxi LiangDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Shaojie ZhengDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Linqiao LiDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Guilin Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNatural cytotoxicity receptor negative innate lymphoid cell (NCR

methodsCOPD mice were induced by cigarette smoking. The pathology in lung was detected in histology. The frequency of NCR

resultsThe frequency of NCR

conclusionsNCR

Indexed as

Cigarette SmokingPulmonary Disease, Chronic ObstructiveAnimalsCadherinsImmunity, InnateInterleukin-17LungLymphocytesMiceNuclear Receptor Subfamily 1, Group F, Member 3VimentinCadherinsInterleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3Vimentincigarette smokingCOPDILC3NCR negative

Identifiers

PMID36988250
PMCPMC10042127
OpenAlexW4361002262

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read19
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.